STERIS, a medical equipment maker, completed the acquisition of Cantel Medical, a global company dedicated to delivering infection prevention products and services, for $3.6bn. “We have long appreciated Cantel, which is a natural complement and extension to STERIS’s product and service offerings, global reach and Customers. Our companies share a similar focus on infection prevention across a range of healthcare Customers. Combined, we will offer a broader set of Customers a more diversified selection of infection prevention and procedural products and services. We welcome the people of Cantel to the STERIS team and firmly believe we will create greater value for our Customers and shareholders together,” Walt Rosebrough, STERIS President and Chief Executive Officer.